Abiopharma

New Form 8-K - WINDTREE THERAPEUTICS INC /DE/ Filed: 2025-06-27 AccNo: 0001437749-25-021453 Size: 653 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment …

New Form 4 - FEMASYS INC Filed: 2025-06-27 AccNo: 0001140361-25-024009 Size: 4 KB

New Form 4 - FEMASYS INC Filed: 2025-06-27 AccNo: 0001140361-25-024007 Size: 4 KB

New Form 4 - FEMASYS INC Filed: 2025-06-27 AccNo: 0001140361-25-024006 Size: 5 KB

New Form 4 - FEMASYS INC Filed: 2025-06-27 AccNo: 0001140361-25-024008 Size: 5 KB

New Form PRE 14A - Moleculin Biotech, Inc. Filed: 2025-06-27 AccNo: 0001437749-25-021447 Size: 3 MB

New Form 4 - Phreesia, Inc. Filed: 2025-06-27 AccNo: 0001127602-25-018177 Size: 8 KB

Notification from CorMedix Inc.

New Form 4 - ARS Pharmaceuticals, Inc. Filed: 2025-06-27 AccNo: 0001415889-25-018406 Size: 14 KB

New Form 8-K - BIOVIE INC. Filed: 2025-06-27 AccNo: 0001520138-25-000190 Size: 189 KB Item 3.03: Material Modifications to Rights of Security Holders

New Form 424B5 - NuCana plc Filed: 2025-06-27 AccNo: 0001193125-25-151464 Size: 623 KB

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2025-06-27 AccNo: 0001214659-25-009732 Size: 48 KB

New Form 424B3 - Biodexa Pharmaceuticals Plc Filed: 2025-06-27 AccNo: 0001214659-25-009733 Size: 48 KB

New Form 8-K - IMMUNIC, INC. Filed: 2025-06-27 AccNo: 0001193805-25-000943 Size: 188 KB Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

New Form 8-K - NEKTAR THERAPEUTICS Filed: 2025-06-27 AccNo: 0001213900-25-059115 Size: 187 KB Item 8.01: Other Events